OJMI  Vol.5 No.2 , June 2015
Superiority of Digital Subtraction for Analysis of Simultaneously-Acquired Dual-Radiopharmaceutical Parathyroid Scintigraphy
Abstract: With dual-radiopharmaceutical (DR) parathyroid scintigraphy, imaging with 99mTcO4-or 123I-NaI is combined with 99mTc-sestamibi scintigraphy for localization of parathyroid adenomas. The set images are then either visually compared or digitally subtracted to aid in interpretation. While both EANM and SNMMI guidelines recommend use of digital subtraction over visual interpretation alone, to date, the few formal comparisons performed have not demonstrated superiority. The purpose of this investigation is to rigorously assess the added value of digital subtraction over visual interpretation alone using simultaneously-acquired 123I-NaI and 99mTc-sestamibi images. Materials: 90 consecutive patients with DR parathyroid scintigraphy for primary hyperparathyroidism who underwent successful parathyroidectomy were included. DR planar acquisition was performed 15 minutes post injection using 10% dual energy windows. Digital subtraction was subsequently performed using commercially available software. Images were independently reviewed by 3 nuclear medicine trainees and 2 experienced nuclear medicine physicians with and without digital subtraction. Results were compared with surgical and histopathologic findings, which served as ground truth. Results: 90 patients had a total of 91 confirmed parathyroid lesions. All 5 readers had significantly greater sensitivity with digital subtraction compared with visual interpretation alone while specificity was not significantly diminished. Area under the ROC curve was significantly greater with digital subtraction in 3 of 5 readers. Agreement was greater among trainees and experienced physicians when using digital subtraction. Conclusion: Using an optimized DR planar co-imaging technique, digital subtraction significantly improved inter-observer agreement and confidence of interpretation and increased sensitivity, without diminishing specificity.
Cite this paper: Pelletier-Galarneau, M. , Sogbein, O. , Dinh, L. and Zuckier, L. (2015) Superiority of Digital Subtraction for Analysis of Simultaneously-Acquired Dual-Radiopharmaceutical Parathyroid Scintigraphy. Open Journal of Medical Imaging, 5, 42-48. doi: 10.4236/ojmi.2015.52007.

[1]   Clarke, B.L. (2013) Epidemiology of Primary Hyperparathyroidism. Journal of Clinical Densitometry, 16, 8-13.

[2]   Delbridge, L.W., Younes, N.A., Guinea, A.I., Reeve, T.S., Clifton-Bligh, P. and Robinson, B.G. (1998) Surgery for Primary Hyperparathyroidism 1962-1996: Indications and Outcomes. The Medical Journal of Australia, 168, 153-156.

[3]   Bilezikian, J.P., Brandi, M.L., Eastell, R., Silverberg, S.J., Udelsman, R., Marcocci, C., et al. (2014) Guidelines for the Management of Asymptomatic Primary Hyperparathyroidism: Summary Statement from the Fourth International Workshop. The Journal of Clinical Endocrinology & Metabolism, 99, 3561-3569.

[4]   Flint, R.S., Harman, C.R., Carter, J. and Snyman, G. (2002) Primary Hyperparathyroidism: Referral Patterns and Outcomes of Surgery. ANZ Journal of Surgery, 72, 200-203.

[5]   Carty, S.E., Worsey, J., Virji, M.A., Brown, M.L. and Watson, C.G. (1997) Concise Parathyroidectomy: The Impact of Preoperative SPECT 99mTc Sestamibi Scanning and Intraoperative Quick Parathormone Assay. Surgery, 122, 1107-1114.

[6]   Worsey, M.J., Carty, S.E. and Watson, C.G. (1993) Success of Unilateral Neck Exploration for Sporadic Primary Hyperparathyroidism. Surgery, 114, 1024-1029.

[7]   Khan, M.A.A., Rafiq, S., Lanitis, S., Mirza, F.A., Gwozdziewicz, L., Al-Mufti, R., et al. (2013) Surgical Treatment of Primary Hyperparathyroidism: Description of Techniques and Advances in the Field. Indian Journal of Surgery, 76, 308-315.

[8]   Lew, J.I. and Solorzano, C.C. (2009) Surgical Management of Primary Hyperparathyroidism: State of the Art. Surgical Clinics of North America, 89, 1205-1225.

[9]   Giordano, A., Rubello, D. and Casara, D. (2001) New Trends in Parathyroid Scintigraphy. European Journal of Nuclear Medicine, 28, 1409-1420.

[10]   Greenspan, B.S., Dillehay, G., Intenzo, C., Lavely, W.C., O’Doherty, M., Palestro, C.J., et al. (2012) SNM Practice Guideline for Parathyroid Scintigraphy 4.0. Journal of Nuclear Medicine Technology, 40, 111-118.

[11]   Hindié, E., Ugur, O., Fuster, D., O’Doherty, M., Grassetto, G., Urea, P., et al. (2009) EANM Parathyroid Guidelines. European Journal of Nuclear Medicine and Molecular Imaging, 36, 1201-1216.

[12]   Ell, P.J., Todd-Pokropek, A. and Britton, K.E. (1975) Localization of Parathyroid Adenomas by Computer-Assisted Parathyroid Scanning. British Journal of Surgery, 62, 553-555.

[13]   Ferlin, G., Borsato, N., Camerani, M., Conte, N. and Zotti, D. (1983) New Perspectives in Localizing Enlarged Parathyroids by Technetium-Thallium Subtraction Scan. Journal of Nuclear Medicine, 24, 438-441.

[14]   Mazzeo, S., Caramella, D., Lencioni, R., Molea, N., De Liperi, A., Marcocci, C., et al. (1996) Comparison among Sonography, Double-Tracer Subtraction Scintigraphy, and Double-Phase Scintigraphy in the Detection of Parathyroid Lesions. American Journal of Roentgenology, 166, 1465-1470.

[15]   Hindié, E., Mellière, D., Jeanguillaume, C., Urea, P., de Labriolle-Vaylet, C. and Perlemuter, L. (2000) Unilateral Surgery for Primary Hyperparathyroidism on the Basis of Technetium Tc 99m Sestamibi and Iodine 123 Subtraction Scanning. Archives of Surgery, 135, 1461-1468.

[16]   Hindié, E., Mellière, D., Jeanguillaume, C., Perlemuter, L., Chéhadé, F. and Galle, P. (1998) Parathyroid Imaging Using Simultaneous Double-Window Recording of Technetium-99m-Sestamibi and Iodine-123. Journal of Nuclear Medicine, 39, 1100-1105.

[17]   O’Doherty, M.J., Kettle, A.G., Wells, P., Collins, R.E. and Coakley, A.J. (1992) Parathyroid Imaging with Technetium-99m-Sestamibi: Preoperative Localization and Tissue Uptake Studies. Journal of Nuclear Medicine, 33, 313-318.

[18]   Krausz, Y., Lebensart, P.D., Klein, M., Weininger, J., Blachar, A., Chisin, R. and Shiloni, E. (2000) Preoperative Localization of Parathyroid Adenoma in Patients with Concomitant Thyroid Nodular Disease. World Journal of Surgery, 24, 1573-1578.

[19]   Caveny, S.A., Klingensmith III, W.C., Martin, W.E., Sage-El, A., McIntyre Jr., R.C., Raeburn, C., et al. (2012) Parathyroid Imaging: The Importance of Dual-Radiopharmaceutical Simultaneous Acquisition with 99mTc-Sestamibi and 123I. Journal of Nuclear Medicine Technology, 40, 104-110.

[20]   Liehn, J.C., Amico, S., Delisle, M.J. and Flament, J.B. (1988) Improvement of Parathyroid Tl-Tc Scintigraphy by Using a New Image Subtraction Method. European Journal of Nuclear Medicine, 14, 184-189.

[21]   Chen, C.C., Holder, L.E., Scovill, W.A., Tehan, A.M. and Gann, D.S. (1997) Comparison of Parathyroid Imaging with Technetium-99m-Pertechnetate/Sestamibi Subtraction, Double-Phase Technetium-99m-Sestamibi and Technetium-99m-Sestamibi SPECT. Journal of Nuclear Medicine, 38, 834-839.

[22]   Obuchowski, N.A., Lieber, M.L. and Powell, K.A. (2000) Data Analysis for Detection and Localization of Multiple Abnormalities with Application to Mammography. Academic Radiology, 7, 516-525.

[23]   McGraw, K.O. and Wong, S.P. (1996) Forming Inferences about Some Intraclass Correlation Coefficients. Psychological Methods, 1, 30-46.

[24]   Landis, J.R. and Koch, G.G. (1977) The Measurement of Observer Agreement for Categorical Data. Biometrics, 33, 159-174.

[25]   Berbaum, K.S., Franken, E.A., Dorfman, D.D., Rooholamini, S.A., Kathol, M.H., Barloon, T.J., et al. (1990) Satisfaction of Search in Diagnostic Radiology. Investigative Radiology, 25, 133-140.

[26]   Nichols, K.J., Tomas, M.B., Tronco, G.G., Rini, J.N., Kunjummen, B.D., Heller, K.S., et al. (2008) Preoperative Parathyroid Scintigraphic Lesion Localization: Accuracy of Various Types of Readings. Radiology, 248, 221-232.

[27]   Lavely, W.C., Goetze, S., Friedman, K.P., Leal, J.P., Zhang, Z., Garret-Mayer, E., et al. (2007) Comparison of SPECT/CT, SPECT, and Planar Imaging with Single- and Dual-Phase 99mTc-Sestamibi Parathyroid Scintigraphy. Journal of Nuclear Medicine, 48, 1084-1089.